Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Jun 5, 2015

Aethlon Medical to Present at the BIO International Convention

Jun 4, 2015

Aethlon Medical Expands Clinical Research Studies to Include Chikungunya Virus

May 26, 2015

Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference

May 13, 2015

Aethlon Medical Announces Health Canada Approval of Ebola Treatment Protocol

May 12, 2015

Aethlon Medical Announces Institutional Review Board Approval of Multi-Indication Cancer Study

May 4, 2015

Aethlon Medical Announces Withdrawal of S-1 Registration Statement

Apr 16, 2015

Aethlon Medical Discloses Presentation of Preliminary CTE Related Study Results

Apr 15, 2015

Aethlon Medical Announces Cancer Clinical Trial Agreement

Apr 14, 2015

Aethlon Medical Announces Effectiveness of Reverse Stock Split

Apr 9, 2015

Aethlon Medical Announces Ebola Humanitarian Use Device Submission to the FDA

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.